Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sinopharm Group Fengliaoxing (Foshan) Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the research, development, and manufacturing of Traditional Chinese Medicine (TCM). As a subsidiary of China Traditional Chinese Medicine Holdings under the Sinopharm Group, it carries a heritage dating back to the Ming Dynasty, originating from the famous Fengliaoxing brand. The company's product portfolio includes various dosage forms such as pills, tablets, capsules, and medicated wines, with a particular focus on orthopedic and rheumatic treatments. It operates modern GMP-certified manufacturing facilities in Foshan, Guangdong Province, and is a key player in the modernization of traditional herbal remedies. The company is recognized as a China Time-honored Brand for its historical significance and quality in herbal medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sinopharm Group Fengliaoxing (Foshan) Pharmaceutical.